© 1991 Oxford University Press
Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility
Shan Zhong,
A. Forbes Howie 1,
Brian Ketterer 2,
John Taylor 2,
John D. Hayes 1,
Geoffrey J. Beckett 1,
Christopher G. Wathen 4,
C.Roland Wolf 4 and
Nigel K. Spurr 5
Human Genetic Resources, Imperial Cancer Research Fund, Clare Hall Laboratories Blanche Lane, South Mimms, Potters Bar, Herts EN6 3LD
1Department of Clinical Chemistry, University of Edinburgh Edinburgh Royal Infirmary. Edinburgh EH3 9YW
2CRC Molecular Toxicology Group, Department of Biochemistry, University College and Middlesex School of Medicine Windeyer Building, Cleveland Street, London WIP 6DB
3Department of Medicine, University of Edinburgh Edinburgh Royal Infirmary, Edinburgh EH3 9YW
4ICRF Molecular Pharmacology Group, Hugh Robson Buildmg, University of Edinburgh George Square, Edinburgh EH8 9XD, UK
5To whom correspondence should be addressed
In mammals, the cytosolic glutathione S-transferases (GSTs; EC 2.5.1.18) are a supergene family comprised of four multigene families, named alpha, mu, pi and theta. In man, withn the mu class gene family there is a gene (the GSTmu 1 locus) that is polymorphic and is only expressed in 5055% of individuals. It has previously been reported, using transstilbene oxide (tSBO) as a specific substrate for the expressed phenotype, that smokers with the null phenotype had a greater susceptibility to lung cancer. In a subsequent study, it was shown that on Southern blot analyses of human DNAs using a GSTmu 1 cDNA probe a DNA fragment was absent in certain individuals. The absence of this band correlated with the tSBO null phenotype. In the present work, DNA clones derived from GST mu class genomic sequences were used as probe in Southern blot analyses and confirmed the correlation between the lack of a DNA fragment and the null phenotype; moreover in this case, using radioimmunoassay for the GST mu protein, these probes were then used in a genotyping assay to investigate further the association of GSTmu 1 polymorphism with susceptibility to lung cancer. It was found that in a control group of 225 individuals, of unknown smoking history, 42% lacked the restriction fragment and were homozgous null, and therefore 58% were either heterozygous or were homozygous normal. Among 228 lung cancer patients, which included all tumour types, a similar distribution occurred, namely 43% were homozygous and 57% were heterozygous or homozygous normal. If, however, the tumours were analysed by tumour type a small but significant positive correlation with the homozygous null genotype was seen in squamous carcinoma of the lung, and an apparently negative correlation with adenocarcinoma of the lung.

CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. W. Reding, N. S. Weiss, C. S. Carlson, C. Chen, C. I. Li, K. E. Malone, K. E. Thummel, and F. M. Farin
Cancer Epidemiol. Biomarkers Prev.,
October 1, 2009;
18(10):
2793 - 2793.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Doroshyenko, U. Fuhr, D. Kunz, D. Frank, M. Kinzig, A. Jetter, Y. Reith, A. Lazar, D. Taubert, J. Kirchheiner, et al.
In vivo Role of Cytochrome P450 2E1 and Glutathione-S-Transferase Activity for Acrylamide Toxicokinetics in Humans
Cancer Epidemiol. Biomarkers Prev.,
February 1, 2009;
18(2):
433 - 443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Carlsten, G. S. Sagoo, A. J. Frodsham, W. Burke, and J. P. T. Higgins
Glutathione S-Transferase M1 (GSTM1) Polymorphisms and Lung Cancer: A Literature-based Systematic HuGE Review and Meta-Analysis
Am. J. Epidemiol.,
April 1, 2008;
167(7):
759 - 774.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-H. S. Chow, I. A. Hakim, D. R. Vining, J. A. Crowell, M. E. Tome, J. Ranger-Moore, C. A. Cordova, D. M. Mikhael, M. M. Briehl, and D. S. Alberts
Modulation of Human Glutathione S-Transferases by Polyphenon E Intervention
Cancer Epidemiol. Biomarkers Prev.,
August 1, 2007;
16(8):
1662 - 1666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Murtaugh, C. Sweeney, K.-n. Ma, B. J. Caan, and M. L. Slattery
The CYP1A1 Genotype May Alter the Association of Meat Consumption Patterns and Preparation with the Risk of Colorectal Cancer in Men and Women
J. Nutr.,
February 1, 2005;
135(2):
179 - 186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Slattery, W. Samowtiz, K. Ma, M. Murtaugh, C. Sweeney, T. R. Levin, and S. Neuhausen
CYP1A1, Cigarette Smoking, and Colon and Rectal Cancer
Am. J. Epidemiol.,
November 1, 2004;
160(9):
842 - 852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Yang, W.R. Bamlet, J.O. Ebbert, W.R. Taylor, and M. de Andrade
Glutathione pathway genes and lung cancer risk in young and old populations
Carcinogenesis,
October 1, 2004;
25(10):
1935 - 1944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L. Keith, Y. E. Miller, T. M. Hudish, C. E. Girod, S. Sotto-Santiago, W. A. Franklin, R. A. Nemenoff, T. H. March, S. P. Nana-Sinkam, and M. W. Geraci
Pulmonary Prostacyclin Synthase Overexpression Chemoprevents Tobacco Smoke Lung Carcinogenesis in Mice
Cancer Res.,
August 15, 2004;
64(16):
5897 - 5904.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Murtaugh, K.-n. Ma, C. Sweeney, B. J. Caan, and M. L. Slattery
Meat Consumption Patterns and Preparation, Genetic Variants of Metabolic Enzymes, and Their Association with Rectal Cancer in Men and Women
J. Nutr.,
April 1, 2004;
134(4):
776 - 784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. A. Hakim, R. B. Harris, H-H. S. Chow, M. Dean, S. Brown, and I. U. Ali
Effect of a 4-Month Tea Intervention on Oxidative DNA Damage among Heavy Smokers: Role of Glutathione S-Transferase Genotypes
Cancer Epidemiol. Biomarkers Prev.,
February 1, 2004;
13(2):
242 - 249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Benhamou, W. J. Lee, A.-K. Alexandrie, P. Boffetta, C. Bouchardy, D. Butkiewicz, J. Brockmoller, M. L. Clapper, A. Daly, V. Dolzan, et al.
Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk
Carcinogenesis,
August 1, 2002;
23(8):
1343 - 1350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Engel, E. Taioli, R. Pfeiffer, M. Garcia-Closas, P. M. Marcus, Q. Lan, P. Boffetta, P. Vineis, H. Autrup, D. A. Bell, et al.
Pooled Analysis and Meta-analysis of Glutathione S-Transferase M1 and Bladder Cancer: A HuGE Review
Am. J. Epidemiol.,
July 15, 2002;
156(2):
95 - 109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-S. Chen, L. S. Chang, H.-W. Chen, and Y.-H. Wei
Polymorphisms of glutathione S-transferase M1 and male infertility in Taiwanese patients with varicocele
Hum. Reprod.,
March 1, 2002;
17(3):
718 - 725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Zhao, A. Seow, E. J. D. Lee, W.-T. Poh, M. Teh, P. Eng, Y.-T. Wang, W.-C. Tan, M. C. Yu, and H.-P. Lee
Dietary Isothiocyanates, Glutathione S-transferase -M1, -T1 Polymorphisms and Lung Cancer Risk among Chinese Women in Singapore
Cancer Epidemiol. Biomarkers Prev.,
October 1, 2001;
10(10):
1063 - 1067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Geisler and A. F. Olshan
GSTM1, GSTT1, and the Risk of Squamous Cell Carcinoma of the Head and Neck: A Mini-HuGE Review
Am. J. Epidemiol.,
July 15, 2001;
154(2):
95 - 105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.B. Nia, F.J. Van Schooten, P.A.E.L. Schilderman, T.M.C.M. De Kok, G.R. Haenen, M.H.M. Van Herwijnen, E. Van Agen, D. Pachen, and J.C.S. Kleinjans
A multi-biomarker approach to study the effects of smoking on oxidative DNA damage and repair and antioxidative defense mechanisms
Carcinogenesis,
March 1, 2001;
22(3):
395 - 401.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Ford, Y. Li, M. M. O'Sullivan, R. Demopoulos, S. Garte, E. Taioli, and P. W. Brandt-Rauf
Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans
Carcinogenesis,
November 1, 2000;
21(11):
1971 - 1975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Lallas, S. K. McClain, M. S. Shahin, and R. E. Buller
The Glutathione S-Transferase M1 Genotype in Ovarian Cancer
Cancer Epidemiol. Biomarkers Prev.,
June 1, 2000;
9(6):
587 - 590.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E. L. Crawford, S. A. Khuder, S. J. Durham, M. Frampton, M. Utell, W. G. Thilly, D. A. Weaver, W. J. Ferencak, C. A. Jennings, J. R. Hammersley, et al.
Normal Bronchial Epithelial Cell Expression of Glutathione Transferase P1, Glutathione Transferase M3, and Glutathione Peroxidase Is Low in Subjects with Bronchogenic Carcinoma
Cancer Res.,
March 1, 2000;
60(6):
1609 - 1618.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
V. W. Setiawan, Z.-F. Zhang, G.-P. Yu, Y.-L. Li, M.-L. Lu, C.-J. Tsai, D. Cordova, M.-R. Wang, C. H. Guo, S.-Z. Yu, et al.
GSTT1 and GSTM1 Null Genotypes and the Risk of Gastric Cancer: A Case-Control Study in a Chinese Population
Cancer Epidemiol. Biomarkers Prev.,
January 1, 2000;
9(1):
73 - 80.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Rojas, I. Cascorbi, K. Alexandrov, E. Kriek, G. Auburtin, L. Mayer, A. Kopp-Schneider, I. Roots, and H. Bartsch
Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism
Carcinogenesis,
January 1, 2000;
21(1):
35 - 41.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rollinson, P. Roddam, E. Kane, E. Roman, R. Cartwright, A. Jack, and G. J. Morgan
Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia
Carcinogenesis,
January 1, 2000;
21(1):
43 - 47.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Woodson, C. Stewart, M. Barrett, N. K. Bhat, J. Virtamo, P. R. Taylor, and D. Albanes
Effect of Vitamin Intervention on the Relationship between GSTM1, Smoking, and Lung Cancer Risk Among Male Smokers
Cancer Epidemiol. Biomarkers Prev.,
November 1, 1999;
8(11):
965 - 970.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. S. Houlston
Glutathione S-Transferase M1 Status and Lung Cancer Risk: A Meta-Analysis
Cancer Epidemiol. Biomarkers Prev.,
August 1, 1999;
8(8):
675 - 682.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
V. Nazar-Stewart, T. L. Vaughan, R. D. Burt, C. Chen, M. Berwick, and G. M. Swanson
Glutathione S-Transferase M1 and Susceptibility to Nasopharyngeal Carcinoma
Cancer Epidemiol. Biomarkers Prev.,
June 1, 1999;
8(6):
547 - 551.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Welfare, A. M. Adeokun, M. F. Bassendine, and A. K. Daly
Polymorphisms in GSTP1, GSTM1, and GSTT1 and Susceptibility to Colorectal Cancer1
Cancer Epidemiol. Biomarkers Prev.,
April 1, 1999;
8(4):
289 - 292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Chen and W. Nirunsuksiri
Decreased expression of glutathione S-transferase M1 in HPV16-transfected human cervical keratinocytes in culture
Carcinogenesis,
April 1, 1999;
20(4):
699 - 703.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Stroombergen and R. H Waring
Determination of glutathione S-transferase {micro} and {tau} polymorphisms in neurological disease
Human and Experimental Toxicology,
March 1, 1999;
18(3):
141 - 145.
[Abstract]
[PDF]
|
 |
|